TD Asset Management
OCDX

TD Asset Management’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

TD Asset Management’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,275,494
Closed -$23.8M – 1535
2022
Q1 		$23.8M Sell
1,275,494
-49,200
-4% -$885K 0.02% 439
2021
Q4 		$28.3M Buy
1,324,694
+506,924
+62% +$9.99M 0.02% 431
2021
Q3 		$15.1M Buy
817,770
+163,018
+25% +$3.28M 0.02% 544
2021
Q2 		$14.7M Buy
654,752
+49,354
+8% +$1M 0.01% 557
2021
Q1 		$11.7M Buy
+605,398
New +$10.7M 0.01% 597

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TD Asset Management's OCDX Position: Q2 2022 in Review

TD Asset Management sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 1,275,494 shares — an estimated $23.8M sold.

TD Asset Management first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $28.3M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • TD Asset Management reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • TD Asset Management sold 1,275,494 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $23.8M.
  • TD Asset Management first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • TD Asset Management's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $28.3M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on TD Asset Management's 13F filing for Q2 2022, filed 4 Aug 2022.